Transaction · 0001415889-25-002003

Baynes Roy D.

Baynes Roy D., DIR, reported a transaction classified as exercise at Travere Therapeutics, Inc. involving 16000.000000 shares for an estimated $280000.00. Reported holdings after the transaction were 47000.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
TVTXTravere Therapeutics, Inc.
Filing timeJan 24
Trade dateJan 23, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

TVTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TVTX since 2025-01-24Filed 587 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001415889-25-002003
Common Stock
Transaction date
Jan 23, 2025
Filed Jan 24, 2025, 01:36 AM · 1d delay
Shares
16.0k sh
$1.75k per share
Estimated value
$28.0M
Computed from shares × price
Holdings after
47.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This sale was made pursuant to a written plan adopted on August 16, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of sha…

  2. F2

    The stock option is fully vested and exercisable.

Original filing · 0001415889-25-002003
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TVTX